BB Biotech AG (BIONn)

Currency in EUR
40.050
+0.950(+2.43%)
Closed·
BIONn Scorecard
Full Analysis
High shareholder yield
High dividend Yield
BIONn is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
39.40040.100
52 wk Range
25.65043.350
Key Statistics
Bid/Ask
39.95 / 40.10
Prev. Close
39.1
Open
39.45
Day's Range
39.4-40.1
52 wk Range
25.65-43.35
Volume
13K
Average Volume (3m)
11.45K
1-Year Change
4.98%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BIONn Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

BB Biotech AG Company Profile

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.

Compare BIONn to Peers and Sector

Metrics to compare
BIONn
Peers
Sector
Relationship
P/E Ratio
−4.7x−3.1x9.8x
PEG Ratio
0.020.010.03
Price/Book
1.1x0.9x1.0x
Price / LTM Sales
−25.2x−3.3x2.9x
Upside (Analyst Target)
54.8%24.1%13.4%
Fair Value Upside
Unlock−5.3%0.8%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -8.02%
Dividend Yield
4.70%
Industry Median 2.17%
Annualised payout
1.88
Paid annually
5-Years Growth
-11.94%
Growth Streak

Earnings

Latest Release
Jul 25, 2025
EPS / Forecast
-1.83 / --
Revenue / Forecast
397.00K / --
EPS Revisions
Last 90 days

BIONn Income Statement

People Also Watch

880.10
ASML
+0.28%
16.460
MDBI
-0.66%
297.85
PRTP
+3.82%
378.9
NOVOb
+2.07%

FAQ

What Stock Exchange Does BB Biotech Trade On?

BB Biotech is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for BB Biotech?

The stock symbol for BB Biotech is "BIONn."

What Is the BB Biotech Market Cap?

As of today, BB Biotech market cap is 2.18B.

What Is BB Biotech's Earnings Per Share (TTM)?

The BB Biotech EPS (TTM) is -8.02.

When Is the Next BB Biotech Earnings Date?

BB Biotech will release its next earnings report on 23 Oct 2025.

From a Technical Analysis Perspective, Is BIONn a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has BB Biotech Stock Split?

BB Biotech has split 2 times.

How Many Employees Does BB Biotech Have?

BB Biotech has 10 employees.

What is the current trading status of BB Biotech (BIONn)?

As of 05 Oct 2025, BB Biotech (BIONn) is trading at a price of 40.050, with a previous close of 39.10. The stock has fluctuated within a day range of 39.400 to 40.100, while its 52-week range spans from 25.650 to 43.350.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.